---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-292567"
form_type: "8-K"
ticker: "CLYM"
cik: "0001768446"
company_name: "Climb Bio, Inc."
filed_at: "2026-07-01T20:15:31+00:00"
generated_at: "2026-07-01T20:17:19.796573+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Climb Bio director Andrew Levin resigns; Breanna O'Reilly elected to board

## Summary
- Andrew Levin resigned from the board effective June 29, 2026.
- Breanna O'Reilly, Ph.D., elected as director effective June 29, 2026.
- O'Reilly received option for 70,284 shares at $13.36, vesting over 3 years.
- O'Reilly to receive $40,000 annual cash retainer and annual equity grants.
- No family relationships or related-party transactions with O'Reilly.

## SEC filing metadata
- accession: 0001193125-26-292567
- form_type: 8-K
- ticker: CLYM
- cik: 0001768446
- company_name: Climb Bio, Inc.
- filed_at: 2026-07-01T20:15:31+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768446/000119312526292567/0001193125-26-292567-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768446/000119312526292567/d61061d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-292567
- JSON: https://secwatch.observer/filing/0001193125-26-292567.json
- Plain text: https://secwatch.observer/filing/0001193125-26-292567.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.